BlackRock Fund Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $306K | Sell |
19,623
-6,116
| -24% | -$95.4K | ﹤0.01% | 3326 |
|
2016
Q3 | $336K | Buy |
25,739
+8,861
| +53% | +$116K | ﹤0.01% | 3308 |
|
2016
Q2 | $116K | Sell |
16,878
-73,227
| -81% | -$503K | ﹤0.01% | 3631 |
|
2016
Q1 | $851K | Sell |
90,105
-5,115
| -5% | -$48.3K | ﹤0.01% | 3197 |
|
2015
Q4 | $959K | Buy |
95,220
+12,742
| +15% | +$128K | ﹤0.01% | 3236 |
|
2015
Q3 | $1.18M | Buy |
+82,478
| New | +$1.18M | ﹤0.01% | 3194 |
|